{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:51:24Z","timestamp":1784310684760,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.vaccine.2015.09.049","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T03:25:52Z","timestamp":1443583552000},"page":"5764-5771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immune modulation of T regulatory cells and IgE responses in horses vaccinated with West Nile virus vaccine combined with a CpG ODN"],"prefix":"10.1016","volume":"33","author":[{"given":"Nicole E.","family":"Behrens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel J.","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.09.049_bib0140","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1016\/j.vaccine.2012.10.029","article-title":"Equine IgE responses to non-viral vaccine components","volume":"30","author":"Gershwin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1017\/S0022172400024232","article-title":"The evaluation of hypersensitivity tests in cattle after foot-and-mouth disease vaccination","volume":"74","author":"Black","year":"1975","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0150","doi-asserted-by":"crossref","first-page":"a2642","DOI":"10.1136\/bmj.a2642","article-title":"Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study","volume":"337","author":"Kang","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0155","first-page":"289","article-title":"Immunotherapeutic applications of CpG-containing oligodeoxynucleotides","volume":"13","author":"Klinman","year":"2000","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0165","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.167.7.3555","article-title":"Cutting edge: role of toll-like receptor 9 in CpG DNA-induced activation of human cells","volume":"167","author":"Takeshita","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0170","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.4049\/jimmunol.167.6.3324","article-title":"Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides","volume":"167","author":"Gursel","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0180","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.157.5.1840","article-title":"Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA","volume":"157","author":"Ballas","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/cimm.1996.0009","article-title":"Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha","volume":"167","author":"Halpern","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0190","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1067\/mai.2001.117795","article-title":"Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells","volume":"108","author":"Horner","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0200","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.4049\/jimmunol.162.10.6284","article-title":"Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides","volume":"162","author":"Sur","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0205","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.4049\/jimmunol.161.9.4463","article-title":"CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice","volume":"161","author":"McCluskie","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-2427(03)00034-5","article-title":"IgE ELISA using antisera derived from epsilon chain antigenic peptides detects allergen-specific IgE in allergic horses","volume":"92","author":"Kalina","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vetimm.2010.11.020","article-title":"Subpopulations of equine blood lymphocytes expressing regulatory T cell markers","volume":"140","author":"Robbin","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0220","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U","article-title":"Identification of CpG oligonucleotide sequences with high induction of IFN-alpha\/beta in plasmacytoid dendritic cells","volume":"31","author":"Krug","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0225","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.166.4.2372","article-title":"Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs","volume":"166","author":"Verthelyi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0230","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","article-title":"Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells","volume":"173","author":"Moseman","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0235","doi-asserted-by":"crossref","first-page":"L667","DOI":"10.1152\/ajplung.2000.278.4.L667","article-title":"IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice","volume":"278","author":"van Scott","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0240","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.vetimm.2005.07.013","article-title":"Temporal regulation of cytokine mRNA expression in equine recurrent airway obstruction","volume":"108","author":"Horohov","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetimm.2003.08.013","article-title":"IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves","volume":"97","author":"Cordeau","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0250","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000066771","article-title":"CpG motifs as possible adjuvants for the treatment of allergic diseases","volume":"129","author":"Bohle","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0260","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0265","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2015.09.049_bib0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vetimm.2011.07.009","article-title":"Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles","volume":"144","author":"Klier","year":"2011","journal-title":"Vet Immunol Immunopathol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:03:54Z","timestamp":1692039834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15013250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":27,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0264410X15013250"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune modulation of T regulatory cells and IgE responses in horses vaccinated with West Nile virus vaccine combined with a CpG ODN","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}